Stryker (NYSE:SYK) issued an update on its first quarter 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.80-1.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.84. Stryker also updated its FY 2019 guidance to $8.00-8.20 EPS.
Several research analysts have weighed in on the company. Credit Suisse Group upgraded Stryker to an outperform rating in a research note on Thursday. Canaccord Genuity lifted their target price on Stryker from $185.00 to $190.00 and gave the company a buy rating in a research note on Wednesday. Cantor Fitzgerald reiterated a neutral rating on shares of Stryker in a research note on Friday, January 18th. Deutsche Bank assumed coverage on Stryker in a research note on Wednesday, January 2nd. They issued a buy rating and a $179.00 target price on the stock. Finally, Morgan Stanley lowered their target price on Stryker from $212.00 to $197.00 and set an overweight rating on the stock in a research note on Wednesday, January 2nd. Eight research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of $182.03.
Shares of SYK stock opened at $179.39 on Thursday. The firm has a market cap of $60.27 billion, a P/E ratio of 24.54, a PEG ratio of 2.01 and a beta of 0.76. Stryker has a 1 year low of $144.75 and a 1 year high of $181.18. The company has a quick ratio of 1.21, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 31st. Investors of record on Monday, December 31st will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, December 28th. This is a boost from Stryker’s previous quarterly dividend of $0.47. This represents a $2.08 annualized dividend and a yield of 1.16%. Stryker’s payout ratio is currently 28.45%.
In related news, VP M Kathryn Fink sold 415 shares of Stryker stock in a transaction on Monday, November 5th. The stock was sold at an average price of $166.56, for a total transaction of $69,122.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Timothy J. Scannell sold 9,332 shares of Stryker stock in a transaction on Tuesday, December 18th. The stock was sold at an average price of $161.60, for a total value of $1,508,051.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,390 shares of company stock valued at $2,845,078. 7.30% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: This story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.themarketsdaily.com/2019/01/31/stryker-syk-updates-q1-2019-earnings-guidance.html.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Read More: What is a blue-chip stock?
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.